TB-500: The Moving Force Behind Tissue Repair Research
It is a seven-amino-acid fragment of a protein found in virtually every cell in your body. Here is what 60 years of TB-500 research studies, from thymus immunology to tissue repair, actually shows.
Research Use Only. Everything in this article is for scientific discussion and education only. Nothing here implies, suggests, or recommends any therapeutic application or use in humans or animals. All QRM products are strictly for in vitro laboratory and research use only by qualified researchers in appropriate facilities.
What exactly is TB-500?
Every cell in your body contains actin. It is one of the most abundant proteins in existence, a structural protein that forms the internal scaffolding cells use to move, divide, and change shape. Without actin working properly, cells cannot migrate. And when cells cannot migrate, wounds do not close, tissues do not repair, and the body's recovery systems stall.
TB-500 is a synthetic fragment of Thymosin Beta-4, a 43-amino-acid peptide found in virtually every nucleated cell in the human body. The specific fragment in TB-500 is just seven amino acids long (the sequence LKKTETQ), but it is the portion of Thymosin Beta-4 responsible for binding actin. That makes it the active region, the part researchers are most interested in when studying how the full protein drives tissue repair.
TB-500 is not an exotic foreign molecule. It is a fragment of something your cells are already producing, constantly, as part of normal biological function. That endogenous origin is a significant part of why TB-500 research studies have attracted decades of sustained attention.
The rescue team that cannot reach the scene
TB-500's primary studied mechanism is actin regulation and, through that, cell migration.
When tissue is damaged, the body needs to send repair cells to the injury site. Those cells have to physically move through tissue to get there. Movement requires each cell to reorganize its internal structure, extending projections forward and retracting at the back. Actin is what makes that movement possible.
TB-500 binds to G-actin (the globular, unassembled form of actin) and helps regulate how and when actin assembles into filaments. In preclinical models, this appears to support the kind of rapid cellular reorganization that lets repair cells migrate efficiently toward injured tissue. Researchers have also observed associated effects on blood vessel formation and inflammation markers, though these are considered secondary signals rather than the primary mechanism.
"If tissue repair is a rescue operation, TB-500 is what helps the rescue team actually reach the scene. Getting there is the first problem. Everything else follows from that."
What changes inside the cell
The toggle below shows a simplified representation of what researchers observe in cellular structure. This is the fundamental mechanism TB-500 research is built around: actin going from scattered monomers to organized filaments that enable directed movement.
Six Decades of TB-500 Research Studies: From Thymus to Tissue Repair
The story of TB-500 does not start with TB-500. It starts in the early 1960s with a group of immunologists trying to understand why the thymus gland matters.
What are scientists actually studying?
TB-500 research studies span a wider range of tissue systems than you might expect from a compound with one primary mechanism.
As with BPC-157, human clinical data for TB-500 specifically is essentially absent. Most human data involves full-length recombinant Thymosin Beta-4, a related but distinct molecule. The preclinical evidence base for the TB-500 fragment is extensive. The clinical picture is still developing.
Compounds researchers study alongside TB-500
TB-500 is frequently investigated alongside compounds that address related but distinct aspects of tissue repair.
Explore TB-500 at QRM
Every batch independently verified. Full Certificate of Analysis on the product page, purity, lot number, test date, archived from day one.
